At the later stages of MS and experimental autoimmune encephalitis, platelets became exhausted in their ability to produce proinflammatory factors and stimulate CD4 T cells but increase their ability to form aggregates with CD4 T cells, thereby decreasing T-cell activation and downmodulating EAE (165). This evidence concerns the gene CD4 and myeloid sarcoma.